Patient characteristics (n = 17) | ||
Age (years) | 65 (9) | |
Male gender, n (%) | 14 (82%) | |
Body mass index (kg m−2) | 25.7 (4.7) | |
Clinical characteristics on study inclusion | ||
Heart rate (bpm) | 95 (26) | |
Systolic arterial pressure (mmHg) | 102 (15) | |
Diastolic arterial pressure (mmHg) | 55 (6) | |
Mean arterial pressure (mmHg) | 69 (7) | |
Norepinephrine therapy, n (%) | 16 (94%) | |
Norepinephrine dose (μg kg−1 min−1) | 0.13 (0.05, 0.38) | |
Mechanical ventilation, n (%) | 12 (71%) | |
Positive end-expiratory pressure (cm H2O) | 8 (6, 9) | |
AVPU score, n (%) | Alert | 2 (12%) |
Verbal | 4 (24%) | |
Passive | 1 (6%) | |
Unresponsive | 10 (58%) | |
Mottling score, n (%) | None | 3 (19%) |
Modest | 2 (13%) | |
Mild | 7 (43%) | |
Moderate | 3 (19%) | |
Severe | 1 (6%) | |
Urine output (mL kg−1 h−1) | 0.49 (0.26, 0.66) | |
Lactate (mmol L−1) | 1.7 (1.4, 3.4) | |
APACHE IV—score (points) | 92 (32) | |
SAPS II— (points) | 56 (17) |